Omega-3 oils support as much attention as ADHD drugs in some children


LONDON (Reuters) – Omega-3 fish oil supplements can improve attention in children with attention deficit hyperactivity disorder (ADHD) just as in drug treatments, except in those people with low omega-3 blood levels of them, showed Wednesday's test results.

Researchers in Britain and Taiwan who launched the placebo test with 92 children said their findings suggest that a "personalized medicine" approach should be adopted in this and other psychiatric conditions.

“The omega-3 supplements only worked in children with lower levels of EPA (eicosapentaenoic acid) in their blood, as if the intervention was restoring a lack of this important nutrient,” said Carmine Pariante. , professor at the Institute of Psychiatry, Psychology & Neurology at King's College London was in charge of the trial.

He said that the work sets a precedent for other nutritional interventions and that it may be the start of “giving the benefits of‘ personalized psychiatry ”to children with ADHD”.

ADHD is a common brain condition that affects around 3% to 7% of people worldwide. Symptoms include problems with attention and sensitivity which create difficulties in academic, work and personal relationships.

In this study, published in Transal Psychiatry, researchers from King and China Medical University in Taiwan conducted a randomized controlled trial with 92 children aged between 6 and 18 years of age with ADHD.

High doses of EPA omega-3 fatty acid, or placebo, were given for 12 weeks.

The results showed that children with the lowest blood levels of the EPA showed improvements in care and attention after taking the omega-3 supplements.

Standard treatments for children with ADHD include mixers such as Ritalin, generously known as methylphenidate, which can improve concentration and focus levels in ADHD patients.

Pariante staff said that while the improved amount of attention and attention from methylphade is usually 0.22 to 0.42, the perceived impact in children with low GCC levels was in the larger trial – at 0.89 for concentrated attention and 0.83 to be observed. give.

But in children with normal EPA levels, there was no improvement on omega-3 supplements, and those with high-EPAs, these supplements were adversely affected by impulsivity symptoms.

Scientists warned that parents should not give fish oil supplements to their children without first checking with a doctor, and stressed that omega-3 levels can be blood tested.

Edited by Andrew Cawthorne

Our Standards:The principles of Thomson Reuters Trust.

(TTTranslate tags) US (t) HEALTH (t) ADHD (t) Hyperactivity Disorder Deficiency Height (T) Housing / Medicine (t) Living / Lifestyle (t) Psychology (t) Europe (t) Mental Illness (t) Pharmaceuticals and Medical Research (TRBC) (t) Health Care (TBC) (t) United Kingdom


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.